COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,357 Articles (22,803 medRxiv, 8,554 bioRxiv)

Most recent first Previous |  Page 283: Articles 2821-2830  | Next

Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis
Aparicio, C., Willis, Z. I., Nakamura, M. M., Wolf, J., Little, C., Maron, G. M., Sue, P. K., Anosike, B. I., Miller, C., Bio, L. L., Singh, P., James, S. H., Oliveira, C. R., PIDS Pediatric COVID-19 Therapies Task Force
10.1101/2024.01.17.24301452 — Posted: 2024-01-18
Altered IgG4 Antibody Response to Repeated mRNA versus Protein COVID Vaccines
Kalkeri, R., Zhu, M., Cloney-Clark, S., Plested, J. S., Parekh, A., Gorinson, D., Cai, R., Mahato, S., Ramanathan, P., Aurelia, L. C., John Selva, K., Marchese, A. M., Fries, L., Chung, A. W., Dunkle, L. M.
10.1101/2024.01.17.24301374 — Posted: 2024-01-18
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)
Jittamala, P., Boyd, S., Schilling, W. H. K., Watson, J. A., Ngamprasertchai, T., Siripoon, T., Luvira, V., Batty, E. M., Wongnak, P., Esper, L. M., Almeida, P. J., Cruz, C., Ascencao, F. R., Aguiar, R. S., Ghanchi, N. K., Callery, J. J., Singh, S., Kruabkontho, V., Ngernseng, T., Tubprasert, J., Madmanee, W., Suwannasin, K., Promsongsil, A., Hanboonkunupakarn, B., Poovorawan, K., Potaporn, M., Srisubat, A., Loharjun, B., Taylor, W. R., Qamar, F. N., Kazi, A. M., Beg, M. A., Chommanam, D., Vidhamaly, S., Chotivanich, K., Imwong, M., Pukrittayakamee, S., Dondorp, A. M., Day, N. P., Teixeira, M.
10.1101/2024.01.16.24301337 — Posted: 2024-01-18
Persistence and Free Chlorine Disinfection of Human Coronaviruses and Their Surrogates in Water
Zhang, M., Leong, M., Mitch, W., Blish, C. A., Boehm, A. B.
10.1101/2024.01.16.575911 — Posted: 2024-01-18
Deciphering the Molecular Mechanism of Post-Acute Sequelae of COVID-19 through Comorbidity Network Analysis
Tian, L., Zhang, Q.
10.1101/2024.01.17.575851 — Posted: 2024-01-18
Sex and gender differences in adverse events following receipt of influenza and COVID-19 vaccination among healthcare workers
Yin, A., Wang, N., Shea, P. J., Rosser, E., Kuo, H., Shapiro, J. R., Fenstermacher, K. Z., Pekosz, A., Rothman, R. E., Klein, S. L., Morgan, R.
10.1101/2024.01.17.24301440 — Posted: 2024-01-18
Why did people not get vaccinated against COVID-19? Results from a nationwide survey among Mexican adults
Wrzecionkowska, D., Stephens, C. R., Gutierrez Reyes, J. P.
10.1101/2024.01.17.24301326 — Posted: 2024-01-17
Predicting COVID-19 Infection Among Older Syrian Refugees in Lebanon: A Multi-Wave Survey
Abi Zeid, B., El Khoury, T., Abdulrahim, S. R., Ghattas, H., McCall, S. J.
10.1101/2024.01.17.24301436 — Posted: 2024-01-17
Clinical Characteristics and Factors Associated with Long COVID in Zambia, August 2020 to January 2023
Malambo, W., Chanda, D., Besa, L., Engamba, D., Mwiinga, L., Mwitumwa, M., Matibula, P., Naik, N., Sivile, S., Agolory, S., Auld, A., Mulenga, L., Hines, J. Z., Fwoloshi, S.
10.1101/2024.01.17.24301423 — Posted: 2024-01-17
Impact of emerging SARS-CoV-2 on total and cause-specific maternal mortality: A natural experiment in Chile during the peak of the outbreak SARS-CoV-2 Impact on Maternal Mortality: Chiles Outbreak Study
Enriquez, Y., Critto, M. E., Weinberg, R., de Janon Quevedo, L., Galleguillos, A., Koch, E.
10.1101/2024.01.17.24301426 — Posted: 2024-01-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).